| 1 |
Czulada E, Tang T, Seau Q, Lankipelle N. Factors Affecting Outcomes of Bone Marrow Stem Cell Therapy for Acute Myocardial Infarction. Georgetown Medical Review 2022. [DOI: 10.52504/001c.57047] [Reference Citation Analysis]
|
| 2 |
Daneshi N, Bahmaie N, Esmaeilzadeh A. Cell-Free Treatments: A New Generation of Targeted Therapies for Treatment of Ischemic Heart Disease. Cell J 2022;24:353-63. [PMID: 36043403 DOI: 10.22074/cellj.2022.7643] [Reference Citation Analysis]
|
| 3 |
Kawaguchi N, Nakanishi T. Stem Cell Studies in Cardiovascular Biology and Medicine: A Possible Key Role of Macrophages. Biology (Basel) 2022;11:122. [PMID: 35053119 DOI: 10.3390/biology11010122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 4 |
Hassanpour M, Cheraghi O, Rahbarghazi R, Nouri M. Autophagy stimulation delayed biological aging and decreased cardiac differentiation in rabbit mesenchymal stem cells. J Cardiovasc Thorac Res 2021;13:234-40. [PMID: 34630972 DOI: 10.34172/jcvtr.2021.43] [Reference Citation Analysis]
|
| 5 |
Arjmand B, Abedi M, Arabi M, Alavi-Moghadam S, Rezaei-Tavirani M, Hadavandkhani M, Tayanloo-Beik A, Kordi R, Roudsari PP, Larijani B. Regenerative Medicine for the Treatment of Ischemic Heart Disease; Status and Future Perspectives. Front Cell Dev Biol 2021;9:704903. [PMID: 34568321 DOI: 10.3389/fcell.2021.704903] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 6 |
Liu SQ, Hou XY, Zhao F, Zhao XG. Nucleated red blood cells participate in myocardial regeneration in the toad Bufo Gargarizan Gargarizan. Exp Biol Med (Maywood) 2021;246:1760-75. [PMID: 34024142 DOI: 10.1177/15353702211013297] [Reference Citation Analysis]
|
| 7 |
Yan C, Xu Z, Huang W. Cellular Senescence Affects Cardiac Regeneration and Repair in Ischemic Heart Disease. Aging Dis 2021;12:552-69. [PMID: 33815882 DOI: 10.14336/AD.2020.0811] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 8 |
Nitahara-Kasahara Y, Kuraoka M, Oda Y, Hayashita-Kinoh H, Takeda S, Okada T. Enhanced cell survival and therapeutic benefits of IL-10-expressing multipotent mesenchymal stromal cells for muscular dystrophy. Stem Cell Res Ther 2021;12:105. [PMID: 33541428 DOI: 10.1186/s13287-021-02168-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 9 |
Rüger BM, Buchacher T, Dauber EM, Pasztorek M, Uhrin P, Fischer MB, Breuss JM, Leitner GC. De novo Vessel Formation Through Cross-Talk of Blood-Derived Cells and Mesenchymal Stromal Cells in the Absence of Pre-existing Vascular Structures. Front Bioeng Biotechnol 2020;8:602210. [PMID: 33330432 DOI: 10.3389/fbioe.2020.602210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 10 |
Askenase PW. COVID-19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies? J Extracell Vesicles 2020;10:e12004. [PMID: 33304473 DOI: 10.1002/jev2.12004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 11 |
Zhang J, Pan J, Jing W. Motivating role of type H vessels in bone regeneration. Cell Prolif 2020;53:e12874. [PMID: 33448495 DOI: 10.1111/cpr.12874] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 12 |
Zarniko N, Skorska A, Steinhoff G, David R, Gaebel R. Dose-Independent Therapeutic Benefit of Bone Marrow Stem Cell Transplantation after MI in Mice. Biomedicines. 2020;8. [PMID: 32545336 DOI: 10.3390/biomedicines8060157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
